Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

Aspo: Several transactions have reshaped the company - Nordea

Aspo

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Aspo sold its Leipurin segment at a relatively good price in Q3 2025. The Telko segment could still suffer from the weak market environment, we argue, but ESL Shipping improved in Q3 compared to H1 2025. Overall industrial activity is not very strong, which could put some pressure on reaching the midpoint of its full-year EBITA guidance of EUR 40m in 2025, yet this guidance of EUR 35-45m includes the Leipurin segment. The same guidance range without Leipurin could be EUR 29-39m, we calculate. We now exclude the Leipurin segment from reported figures on a pro forma basis for 2025E to follow the new reporting structure, which is also the main reason for our estimate revisions. Our long-term growth and margin assumptions point to a new fair value range of EUR 6.7-8.2 (6.3-7.7), based on an equal weighting of our DCF, P/E and SOTP valuations.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.